Pathogenesis of psoriasis in the "omic" era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis.
inflammation
metabolic syndrome
metabolomics
proteomic nutrigenomics
psoriasis
Journal
Postepy dermatologii i alergologii
ISSN: 1642-395X
Titre abrégé: Postepy Dermatol Alergol
Pays: Poland
ID NLM: 101168357
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
31
03
2020
accepted:
28
05
2020
entrez:
30
9
2020
pubmed:
1
10
2020
medline:
1
10
2020
Statut:
ppublish
Résumé
Psoriasis is a systemic disease that is strictly connected with metabolic disorders (insulin resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It occurs more often in patients with a more severe course of the disease. Obesity is specially an independent risk factor and it is associated with a worse treatment outcome because of the high inflammatory activity of visceral fatty tissue and the production of inflammatory mediators involved in the development of both psoriasis and metabolic disorders. However, in psoriasis the activation of the Th17/IL-17 and the abnormalities in the Th17/Treg balance axis are observed, but this pathomechanism does not fully explain the frequent occurrence of metabolic disorders. Therefore, there is a need to look for better biomarkers in the diagnosis, prognosis and monitoring of concomitant disorders and therapeutic effects in psoriasis. In addition, the education on the use of a proper diet as a prophylaxis for the development of the above disorders is an important element of holistic care for a patient with psoriasis. Diet may affect gene expression due to epigenetic modification which encompasses interactions of environment, nutrition and diseases. Patients with psoriasis should be advised to adopt proper diet and dietician support.
Identifiants
pubmed: 32994764
doi: 10.5114/ada.2020.98284
pii: 98284
pmc: PMC7507147
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
452-467Informations de copyright
Copyright: © 2020 Termedia Sp. z o. o.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Cell Immunol. 2016 May;303:7-15
pubmed: 27071377
J Dermatol. 2019 Aug;46(8):695-701
pubmed: 31149744
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1876-1885
pubmed: 27230733
Nutrients. 2018 Dec 03;10(12):
pubmed: 30513929
Nutrients. 2016 Mar 02;8(3):128
pubmed: 26950145
J Cutan Pathol. 2018 Jan;45(1):23-28
pubmed: 29023827
Skin Pharmacol Physiol. 2015;28(4):177-88
pubmed: 25620035
Br J Dermatol. 2012 Aug;167(2):436-9
pubmed: 22486212
Br J Dermatol. 2012 Mar;166(3):505-10
pubmed: 22013980
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8537-8551
pubmed: 30556896
Nutrition. 2009 Mar;25(3):295-302
pubmed: 19041224
Indian J Dermatol. 2019 May-Jun;64(3):201-206
pubmed: 31148858
Genomics Proteomics Bioinformatics. 2015 Aug;13(4):224-33
pubmed: 26362816
Sci Rep. 2016 Jan 19;6:19295
pubmed: 26781963
Int J Mol Sci. 2014 Dec 26;16(1):378-400
pubmed: 25548896
Eur Rev Med Pharmacol Sci. 2016 May;20(9):1675-9
pubmed: 27212156
Pol Arch Intern Med. 2018 Aug 31;128(7-8):434-439
pubmed: 30057390
Free Radic Res. 2016 Jun;50(6):585-95
pubmed: 27098416
Int J Dermatol. 2017 Mar;56(3):260-268
pubmed: 27696392
Curr Rheumatol Rep. 2015 May;17(5):35
pubmed: 25895652
J Nutr. 2016 Aug;146(8):1560-70
pubmed: 27358416
JAMA Dermatol. 2018 Aug 1;154(8):934-950
pubmed: 29926091
J Transl Med. 2015 Jan 27;13:18
pubmed: 25622660
PLoS One. 2017 Apr 27;12(4):e0174880
pubmed: 28448590
Adv Anat Embryol Cell Biol. 2012;212:v, vii, 1-115
pubmed: 22894052
J Am Heart Assoc. 2013 Apr 04;2(2):e000062
pubmed: 23557749
Exp Dermatol. 2017 Apr;26(4):299-304
pubmed: 28156019
Expert Opin Drug Discov. 2018 Sep;13(9):875-887
pubmed: 30124339
PLoS One. 2019 Feb 8;14(2):e0211808
pubmed: 30735527
J Am Acad Dermatol. 2019 Jun;80(6):1682-1690
pubmed: 30797850
Exp Dermatol. 2011 Feb;20(2):81-7
pubmed: 21255085
J Am Acad Dermatol. 2014 Sep;71(3):561-9
pubmed: 24780177
Sci Transl Med. 2014 Feb 26;6(225):225re1
pubmed: 24574341
J Lipid Res. 2009 Apr;50 Suppl:S86-90
pubmed: 19033209
J Nutr Biochem. 2011 Mar;22(3):293-9
pubmed: 20579867
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
Folia Med (Plovdiv). 2013 Jan-Mar;55(1):25-32
pubmed: 23905484
Clin Rev Allergy Immunol. 2013 Oct;45(2):217-26
pubmed: 23359064
Curr Opin Toxicol. 2018 Apr;8:66-80
pubmed: 29568812
Int J Mol Sci. 2017 Jan 29;18(2):
pubmed: 28146070
Dermatology. 2010;220(1):32-7
pubmed: 19887761
Herz. 2012 Aug;37(5):527-33
pubmed: 22127739
Genes Immun. 2020 May;21(3):150-168
pubmed: 32203088
Front Endocrinol (Lausanne). 2012 Jan 03;2:102
pubmed: 22654837
Nutrients. 2019 Mar 12;11(3):
pubmed: 30871045
Eur J Immunol. 2009 Sep;39(9):2629-35
pubmed: 19662632
Public Health Nutr. 2011 Dec;14(12A):2274-84
pubmed: 22166184
J Drugs Dermatol. 2014 Feb;13(2):111-8
pubmed: 24509958
Oxid Med Cell Longev. 2019 Apr 16;2019:2304018
pubmed: 31178954
Medicine (Baltimore). 2016 May;95(20):e3576
pubmed: 27196459
Exp Dermatol. 2011 Apr;20(4):303-7
pubmed: 21410760
Int J Mol Sci. 2019 May 13;20(9):
pubmed: 31085992
Cytokine. 2013 Mar;61(3):898-905
pubmed: 23332504
Arch Intern Med. 2007 Aug 13-27;167(15):1670-5
pubmed: 17698691
Ann Rheum Dis. 2012 Aug;71(8):1273-7
pubmed: 22586165
Epigenetics. 2018;13(2):156-162
pubmed: 28055298
Rev Port Cardiol. 2015 Oct;34(10):613-6
pubmed: 26417656
J Dermatolog Treat. 2014 Feb;25(1):18-21
pubmed: 23441953
J Exp Med. 2009 Jan 16;206(1):249-58
pubmed: 19114666
J Eur Acad Dermatol Venereol. 2014 Jan;28(1):116-9
pubmed: 22882471
Ann N Y Acad Sci. 2015 Aug;1348(1):97-106
pubmed: 26190093
J Cutan Med Surg. 2016 Jul;20(4):327-33
pubmed: 26316538
Wiad Lek. 2005;58(11-12):670-4
pubmed: 16594480
Int J Mol Sci. 2019 Mar 06;20(5):
pubmed: 30845706
J Atheroscler Thromb. 2010 Apr 30;17(4):332-41
pubmed: 20124732
Clin Rev Allergy Immunol. 2016 Jun;50(3):377-89
pubmed: 27025861
Postepy Dermatol Alergol. 2019 Jun;36(3):319-328
pubmed: 31333349
Mediators Inflamm. 2019 May 28;2019:7353420
pubmed: 31275060
Dermatology. 2012;225(1):88-92
pubmed: 22986416
J Nutr Biochem. 2008 Jun;19(6):371-5
pubmed: 17614271
J Am Acad Dermatol. 2014 Aug;71(2):350-8
pubmed: 24780176
Arch Dermatol Res. 2016 Apr;308(3):207-12
pubmed: 26842230
Br J Clin Pharmacol. 2013 Mar;75(3):645-62
pubmed: 22765297
ScientificWorldJournal. 2010 Nov 16;10:2265-71
pubmed: 21103795
PLoS One. 2016 Feb 24;11(2):e0149316
pubmed: 26910469
Dermatol Ther (Heidelb). 2017 Jun;7(2):227-242
pubmed: 28526915
Pharmacol Res. 2012 May;65(5):523-30
pubmed: 22402395
J Invest Dermatol. 2018 Sep;138(9):1999-2009
pubmed: 29605673
J Saudi Heart Assoc. 2014 Apr;26(2):63-71
pubmed: 24719535
Nat Rev Immunol. 2011 Feb;11(2):85-97
pubmed: 21252989
Int J Mol Sci. 2018 Oct 08;19(10):
pubmed: 30297679
Arch Dermatol Res. 2013 Mar;305(2):113-6
pubmed: 23291856
Br J Dermatol. 2013 Apr;168(4):749-55
pubmed: 23110708
J Cell Physiol. 2010 Apr;223(1):36-48
pubmed: 20020487
J Proteomics. 2011 Dec 21;75(2):677-94
pubmed: 21964257
J Steroid Biochem Mol Biol. 2015 Jul;151:25-37
pubmed: 25448732
J Invest Dermatol. 2010 Jul;130(7):1785-96
pubmed: 20445552
Biochem Pharmacol. 2009 Jun 15;77(12):1835-44
pubmed: 19428338
Prostaglandins Other Lipid Mediat. 2018 Jan;134:131-140
pubmed: 28802571
J Am Acad Dermatol. 2013 Mar;68(3):511-2
pubmed: 23394917
J Dermatol Sci. 2008 Nov;52(2):123-9
pubmed: 18585007
Acta Dermatovenerol Alp Pannonica Adriat. 2017 Mar;26(1):3-9
pubmed: 28352928
Postepy Hig Med Dosw (Online). 2017 Aug 24;71(1):761-772
pubmed: 28894050
Int J Rheum Dis. 2017 Apr;20(4):442-450
pubmed: 28261950
Int J Mol Sci. 2017 Oct 21;18(10):
pubmed: 29065479
Curr Health Sci J. 2013 Oct;39(4):225-31
pubmed: 24778862
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):327-32
pubmed: 23432373
Ther Adv Chronic Dis. 2019 Aug 07;10:2040622319864805
pubmed: 31431821
Arch Dermatol Res. 2002 Feb;293(12):620-5
pubmed: 11875645
Front Immunol. 2014 Aug 12;5:368
pubmed: 25161652
Rev Endocr Metab Disord. 2017 Jun;18(2):195-205
pubmed: 28176237
J Am Soc Nephrol. 2006 Dec;17(12):3438-46
pubmed: 17082236
Toxicol Lett. 2013 Aug 29;221(3):219-24
pubmed: 23830989
Exp Dermatol. 2012 Apr;21(4):312-4
pubmed: 22417311
Atherosclerosis. 2012 Jul;223(1):1-68
pubmed: 22698795
Carcinogenesis. 2010 Sep;31(9):1561-6
pubmed: 20622002
JAMA Dermatol. 2018 Sep 1;154(9):1017-1024
pubmed: 30046840
Front Microbiol. 2019 Feb 21;10:236
pubmed: 30846974
Psoriasis (Auckl). 2017;7:1-15
pubmed: 28824870
Acta Derm Venereol. 2020 Jan 30;100(3):adv00033
pubmed: 31971602
Clin Exp Med. 2020 Feb;20(1):39-48
pubmed: 31758356
Rheumatol Int. 2017 Jan;37(1):97-105
pubmed: 27221457
Br J Dermatol. 2005 Oct;153(4):706-14
pubmed: 16181450
Mol Cell Biochem. 2013 Oct;382(1-2):137-43
pubmed: 23793554
Int J Obes (Lond). 2009 Jan;33(1):151-6
pubmed: 18982006
Eur J Epidemiol. 2018 Dec;33(12):1163-1178
pubmed: 29680995
Br J Dermatol. 2011 Oct;165(4):743-50
pubmed: 21564065
Cancer Prev Res (Phila). 2013 May;6(5):483-94
pubmed: 23503652
J Dermatolog Treat. 2015 Jun;26(3):230-4
pubmed: 25102892
Eur J Endocrinol. 2006 Jan;154(1):83-6
pubmed: 16381995
Dermatology. 2008;217(4):365-73
pubmed: 18810241
J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29
pubmed: 23845149
Actas Dermosifiliogr. 2014 Jan-Feb;105(1):31-44
pubmed: 23177976
J Invest Dermatol. 2009 Oct;129(10):2411-8
pubmed: 19458634
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11467-72
pubmed: 25049417